XML 39 R40.htm IDEA: XBRL DOCUMENT v2.4.0.6
Summary Of Changes In SARs Outstanding (Detail) (USD $)
6 Months Ended
Jun. 30, 2012
Year
Weighted Average Remaining Contractual Term  
Granted 1.4
Stock Appreciation Rights
 
SARs  
Beginning Balance 2,500,000
Granted 400,000
Forfeited   
Exercised (500,000)
Ending Balance 2,400,000 [1],[2]
Vested and exercisable at June 30, 2012 1,300,000 [2]
Per Share Weighted Average Exercise Price  
Beginning Balance 20.39
Granted 37.81
Forfeited   
Exercised 18.68
Ending Balance 23.45 [1],[2]
Vested and exercisable at June 30, 2012 18.50 [2]
Per Share Weighted Average Grant Date Fair Value  
Beginning Balance 7.66
Granted 12.99
Forfeited   
Exercised 7.11
Ending Balance 8.60 [1],[2]
Vested and exercisable at June 30, 2012 6.93 [2]
Weighted Average Remaining Contractual Term  
Beginning Balance 4
Granted 6.61
Forfeited 0
Exercised 0
Ending Balance 4.20 [1],[2]
Vested and exercisable at June 30, 2012 3.18 [2]
[1] As of June 30, 2012, 1.1 million of the SARs outstanding were unvested. The Company expects that substantially all of these unvested awards will vest in future periods.
[2] As of June 30, 2012, total SARs outstanding had an intrinsic value of $47.5 million. SARs vested and exercisable had an intrinsic value of $31.1 million.